Synergistic Cardiac Ablation Systems

Publication ID: 24-11857250_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Cardiac Ablation Systems,” Published Technical Disclosure No. 24-11857250_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857250_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,250.

Summary of the Inventive Concept

The present invention integrates a semi-circular ablation catheter with distinct technologies, such as AI, IoT, blockchain, and novel nanomaterials, to create a more powerful and efficient cardiac ablation system.

Background and Problem Solved

The original semi-circular ablation catheter, while effective, has limitations in terms of navigation, data management, and treatment optimization. The present invention addresses these limitations by combining the catheter with advanced technologies to enhance treatment outcomes and patient care.

Detailed Description of the Inventive Concept

The synergistic cardiac ablation system comprises a semi-circular ablation catheter integrated with an AI-powered navigation module, an IoT-enabled patient monitoring system, a blockchain-based data storage module, and a novel nanomaterial-based electrode. The AI-powered navigation module optimizes treatment patterns, while the IoT-enabled patient monitoring system provides real-time patient data. The blockchain-based data storage module ensures secure and transparent data management. The novel nanomaterial-based electrode enhances ablation efficiency. The system utilizes machine learning algorithms to analyze patient data and predict optimal treatment outcomes.

Novelty and Inventive Step

The integration of the semi-circular ablation catheter with AI, IoT, blockchain, and novel nanomaterials is new and non-obvious, as it combines distinct technologies to create a more powerful and efficient cardiac ablation system. The use of machine learning algorithms to analyze patient data and predict optimal treatment outcomes is also novel and inventive.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the semi-circular ablation catheter with robotic-assisted navigation systems, machine learning-based patient profiling modules, or AI-powered treatment planning modules. Variations could also include using different types of advanced materials or technologies to enhance ablation efficiency and treatment outcomes.

Potential Commercial Applications and Market

The synergistic cardiac ablation system has significant commercial potential in the medical device industry, particularly in the areas of cardiac arrhythmia treatment and patient care. The system's ability to enhance treatment outcomes, reduce procedure time, and provide secure and transparent data management makes it an attractive solution for hospitals, clinics, and medical professionals.

CPC Classifications

SectionClassGroup
A A61 A61B18/1492
A A61 A61B2017/003
A A61 A61B2018/00351
A A61 A61B2018/00357
A A61 A61B2018/00375
A A61 A61B2018/00577
A A61 A61B2018/00642
A A61 A61B2018/00702
A A61 A61B2018/00726
A A61 A61B2018/00821
A A61 A61B2018/1407
A A61 A61B2018/1467
A A61 A61B2018/1807

Original Patent Information

Patent NumberUS 11,857,250
TitleSemi-circular ablation catheter
Assignee(s)Medtronic Ablation Frontiers LLC